Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Alert for Industry Human and Animal Drugs
  • Print
  • Share
  • E-mail
-

Human and Animal Drugs


DWPE = Detain without physical examination
Import Alert Number Import Alert Type Publish Date Import Alert Name
16-81 DWPE 08/28/2015 "Detention Without Physical Examination of Seafood Products Due to the Presence of Salmonella"
45-06 DWPE 07/22/2015 "Detention without Physical Examination of Stevia Leaves, Crude Extracts of Stevia Leaves and foods Containing Stevia Leaves and/or Stevia Extracts"
54-16 DWPE 07/07/2015 "DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS THAT ARE MARKETED AS FOODS, INCLUDING PRODUCTS MARKETED AS DIETARY SUPPLEMENTS, THAT CONTAIN AN ACTIVE PHARMACEUTICAL INGREDIENT"
55-03 DWPE 09/09/2014 DETENTION WITHOUT PHYSICAL EXAMINATION OF DIFFERENT FORMS OF HEPARIN AND HEPARIN-RELATED PRODUCTS
61-01 DWPE 07/26/2013 "Gerovital (KH3 - GH3, Etc.)"
61-05 DWPE 03/18/2011 "Methapyrilene and Drug Products Containing Methapyrilene"
61-06 DWPE 12/14/2012 "Detention Without Physical Examination of Skin Cap Spray, Shampoo And Cream"
61-07 DWPE 03/12/2012 Detention Without Physical Examination of Domperidone"
62-05 DWPE 04/04/2014 "Sterile Dosage Form Drugs"
62-07 DWPE 12/14/2012 "Detention Without Physical Examination of Shipments of Sygen Injectable (Bovine-Extracted GMI Monosialoganglioside)"
66-05 DWPE 12/14/2012 "Foreign Labeled Finished Dosage Parenterals"
66-10 DWPE 03/18/2011 Chinese Herbal Medicines
66-14 DWPE with Surveillance 09/17/2014 "Reimportation of All Prescription Drugs for Human Use"
66-35 DWPE with Surveillance 03/27/2015 "Detention Without Physical Examination of Redotex and Other Diet Pills From Mexico"
66-40 DWPE 08/21/2015 "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"
66-41 DWPE 09/03/2015 Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
66-57 DWPE 12/14/2012 "Detention Without Physical Examination Of Foreign manufactured Unapproved Prescription Drugs Promoted to Individuals in the U.S."
66-65 DWPE 10/12/2011 "Detention Without Physical Examination Of Reimportation Of Insulin"
66-66 DWPE 06/04/2015 "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
66-72 DWPE 12/14/2012 "Detention Without Physical Examination Of Misbranded Drugs And Marketed New Drugs Without Approved Applications"
66-75 DWPE 06/26/2012 DETENTION WITHOUT PHYSICAL EXAMINATION OF IMMUNO-AUGMENTATIVE THERAPY (IAT)
68-19 DWPE 08/14/2015 "DETENTION WITHOUT PHYSICAL EXAMINATION OF UNAPPROVED NEW ANIMAL DRUGS"
99-32 DWPE 05/18/2015 "DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS FROM FIRMS REFUSING FDA FOREIGN ESTABLISHMENT INSPECTION"
99-34 DWPE 05/21/2015 DETENTION WITHOUT PHYSICAL EXAMINATION OF DRUGS OR MEDICAL DEVICES FROM FIRMS WITHOUT A VALID DRUG OR MEDICAL DEVICE REGISTRATION
-
-